Written by Klarity Editorial Team
Published: Jul 16, 2026

Last updated: July 16, 2026
Key update — Medicare GLP-1 Bridge (July 1, 2026): Starting July 1, 2026, eligible Humana Medicare Advantage members in West Virginia may access Wegovy (semaglutide), Zepbound (tirzepatide), and Foundayo at $50/month through a new CMS program — outside the standard HPS Part D formulary. This program is available to qualifying Medicare Advantage Prescription Drug (MAPD) plan members. Contact CMS at 1-800-633-4227 or your Humana plan for eligibility details.
Important: Humana operates as Medicare Advantage only in West Virginia — Humana no longer offers commercial (employer or individual) health plans in this state. This guide covers Humana Medicare Advantage plans only.
→ Check if Klarity’s weight loss providers may accept your Humana MA plan
Last updated: July 16, 2026
Weight loss treatment coverage under Humana Medicare Advantage plans in West Virginia depends on your specific plan, your body mass index (BMI), documented comorbidities, and whether the medication or service is included in your plan’s benefits. Humana’s Medicare Advantage plans are administered through Humana Pharmacy Solutions (HPS) for prescription benefits and are governed by federal CMS regulations — not West Virginia state insurance law.
As of July 1, 2026, a landmark Medicare GLP-1 Bridge program gives eligible MAPD members access to Wegovy, Zepbound, and Foundayo at $50/month through CMS — a significant change for West Virginia Medicare Advantage members seeking GLP-1 coverage.
This guide covers the HPS Part D formulary for weight loss medications, the Medicare GLP-1 Bridge program, prior authorization requirements, EPCS prescribing rules, parity rights, and how to verify your benefits.
The Medicare GLP-1 Bridge is a CMS-administered program that launched July 1, 2026, providing Medicare Advantage Prescription Drug (MAPD) plan members access to FDA-approved GLP-1 weight loss medications at a reduced cost:
Important distinction: Mounjaro (tirzepatide) and Ozempic/Rybelsus (semaglutide) are indicated for type 2 diabetes management — they are separate from Zepbound and Wegovy, which are the FDA-approved weight loss formulations. The GLP-1 Bridge covers the weight loss formulations specifically.
Outside the Medicare GLP-1 Bridge program, standard Part D coverage for weight loss medications has historically been limited. The table below reflects typical HPS formulary tier placement for Part D plans — individual plan formularies vary and members should verify with their specific plan.
| Medication | Type | Typical Tier | PA Required? | Schedule | Notes |
|---|---|---|---|---|---|
| Wegovy (semaglutide 2.4 mg) | GLP-1 agonist | Specialty / Bridge program | Yes (or Bridge eligibility) | Non-scheduled | Access via Medicare GLP-1 Bridge at $50/mo from July 2026 |
| Zepbound (tirzepatide) | GLP-1/GIP agonist | Specialty / Bridge program | Yes (or Bridge eligibility) | Non-scheduled | Access via Medicare GLP-1 Bridge at $50/mo from July 2026 |
| Foundayo | GLP-1 agonist | Bridge program | Bridge eligibility criteria | Non-scheduled | Available via CMS Bridge program July 2026 |
| Saxenda (liraglutide 3 mg) | GLP-1 agonist | Tier 4–5 (specialty) | Yes — BMI + comorbidity | Non-scheduled | Verify with plan; not included in GLP-1 Bridge |
| Contrave (naltrexone/bupropion) | Combination | Tier 3–4 | PA likely | Non-scheduled | Bupropion component non-controlled; naltrexone non-scheduled |
| Orlistat (Xenical) | Lipase inhibitor | Tier 1–2 | Usually no PA | Non-scheduled | Alli 60mg OTC — not covered under Part D |
| Phentermine (generic) | Stimulant — short-term | Tier 1–2 | Quantity limits | Schedule IV — EPCS required | Short-term use only; prescriber must use EPCS-compliant system |
| Qsymia (phentermine/topiramate ER) | Combination | Tier 2–3 | PA + REMS | Schedule IV + REMS | EPCS required; REMS certification required at prescriber and pharmacy level |
| Mounjaro (tirzepatide) | GLP-1/GIP — diabetes indication | Tier 3–4 (diabetes coverage) | PA — diabetes diagnosis required | Non-scheduled | NOT for weight loss indication under Part D; separate from Zepbound |
| Ozempic / Rybelsus (semaglutide) | GLP-1 — diabetes indication | Tier 3–4 (diabetes coverage) | PA — diabetes diagnosis required | Non-scheduled | NOT for weight loss indication under Part D; separate from Wegovy |
Formulary tiers and PA requirements vary by specific Humana MA plan. Always verify with HPS (1-800-379-0092) or your plan’s Evidence of Coverage document.
West Virginia requires electronic prescribing of controlled substances (EPCS) under W. Va. Code § 60A-4-403a, which applies to all controlled substances — not just Schedule II. This is broader than most states, which typically limit EPCS mandates to Schedule II.
EPCS applicability by medication:
Klarity Health providers operate EPCS-compliant prescribing systems and are able to prescribe Schedule IV medications including phentermine where clinically appropriate and legally permissible.
Most weight loss medications under Humana Medicare Advantage require prior authorization. Typical PA criteria may include:
How to submit PA requests for Humana MA in West Virginia:
WV SB 267 (2024) — note on applicability: West Virginia SB 267 requires electronic PA submission via Availity for state-regulated commercial insurers. However, Humana Medicare Advantage plans are federally regulated under 42 U.S.C. § 1395w-26(b)(3) — federal preemption applies, and SB 267 does not govern Humana MA. Availity remains a valid and preferred submission channel, but the legal basis is federal MA requirements rather than WV SB 267.
CMS Part D PA decision timelines (Medicare Advantage):
West Virginia’s mental health parity law (W. Va. Code § 33-25-8r et seq.) covers mental health and substance use disorder benefits. It does not govern weight loss treatment coverage — weight loss is not classified as a mental health or substance use disorder condition under WV parity statute.
Weight loss treatment coverage for Humana Medicare Advantage members in West Virginia is governed by:
Under Medicare Advantage, CMS enforces federal parity and benefit requirements. Members may file complaints or grievances with CMS at 1-800-633-4227 or at medicare.gov/claims-appeals.
For Medicare Advantage, WV Insurance Commissioner oversight is limited. The primary regulatory authority for benefit disputes is CMS, not the WV Insurance Commissioner. If you need regulatory assistance, contact CMS directly rather than (or in addition to) the WV Insurance Commissioner at 1-888-879-9842.
Beyond prescription medications, Humana Medicare Advantage plans in West Virginia may cover additional weight management services:
Klarity Health has 2,000+ licensed providers offering telehealth weight loss treatment, including GLP-1 medication management, across West Virginia. Klarity providers work with Medicare Advantage patients and can assist with:
See if Klarity’s weight loss providers may be covered under your Humana MA plan →
Disclaimer: Humana Medicare Advantage is a federally regulated private health plan for Medicare-eligible individuals (typically age 65+, or with qualifying disability). It is not the same as West Virginia Medicaid (Mountain Health Trust), which is a separate state-federal program administered by the WV Department of Health and Human Resources (DHHR). WV Medicaid is for low-income residents and is not administered by Humana in West Virginia. For WV Medicaid questions, contact WV DHHR at 1-800-642-8589.
Traditionally, Medicare Part D excluded weight loss drugs. However, as of July 1, 2026, eligible Humana MAPD members may access Wegovy at $50/month through the CMS Medicare GLP-1 Bridge program — outside the standard Part D formulary. Contact Humana at 1-800-448-6262 or CMS at 1-800-633-4227 to verify your plan’s participation and your eligibility.
Zepbound (tirzepatide for weight loss) may be accessible to eligible Humana MAPD members at $50/month through the Medicare GLP-1 Bridge program starting July 1, 2026. Note that Mounjaro — which contains the same active ingredient but is indicated for type 2 diabetes — is a separate medication with different coverage criteria.
Yes. Phentermine is a Schedule IV controlled substance. Under W. Va. Code § 60A-4-403a, West Virginia requires electronic prescribing (EPCS) for all controlled substances, including Schedule IV. Prescribers must use a DEA-compliant EPCS system to prescribe phentermine in WV. Paper prescriptions are generally not permitted for outpatient phentermine prescribing in this state.
No. West Virginia’s mental health parity statute (W. Va. Code § 33-25-8r et seq.) covers mental health and substance use disorder benefits only. It does not govern weight loss treatment coverage. Weight loss coverage for Humana MA members is governed by CMS 42 CFR Part 422 and your plan’s Evidence of Coverage, not by WV state parity law.
Yes. Under CMS rules, you have the right to request a Medicare Advantage coverage determination, redetermination, Independent Review Entity (IRE) review, ALJ hearing, and further appeals. Timelines: standard redetermination 7 days; expedited 72 hours; IRE standard 60 days. Contact Humana at 1-800-448-6262 or CMS at 1-800-633-4227 for help with appeals.
No. WV SB 267 (2024), which requires electronic PA submission via Availity for state-regulated commercial insurers, does not apply to Humana Medicare Advantage. MA plans are federally regulated under 42 U.S.C. § 1395w-26(b)(3), which preempts state insurance mandates. Humana MA members and providers should submit PA requests via Availity or humana.com/providers — the legal basis is federal MA requirements, not WV SB 267.
Disclaimer: Coverage information in this guide is based on publicly available information and is provided for educational purposes only. Coverage may vary significantly by specific Humana Medicare Advantage plan, formulary year, and individual member circumstances. Klarity Health is not affiliated with Humana or CMS. Always verify your specific benefits directly with Humana (1-800-448-6262), HPS (1-800-379-0092), or CMS (1-800-633-4227) before beginning treatment. This content does not constitute medical or legal advice.
Find the right provider for your needs — select your state to find expert care near you.